In patients with amnestic mild cognitive impairment and Alzheimer’s disease, IL-1beta is expressed in higher levels in the plasma, cerebrospinal fluid (CSF), and in certain brain regions, especially in the frontal cortex and hippocampus, and the concentration of IL-1beta negatively correlates with cognitive performance [27–29]. Here, IL1B is linked to Alzheimer disease.